Federation Des Caisses Desjardins Du Quebec Johnson & Johnson Transaction History

Federation Des Caisses Desjardins Du Quebec

$17.5 Billion
Q2 2024

A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Johnson & Johnson stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 573,004 shares of JNJ stock, worth $95.2 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

573,004

Previous 556,518 2.96%

Holding current value

$95.2 Million

Previous $88 Billion 99.9%

% of portfolio

0.48%

Previous 0.64%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$144.38 - $157.78 $2.38 Million - $2.6 Million	16,486 Added 2.96%	573,004 $83.8 Million
Q1 2024 May 15, 2024	BUY	$155.22 - $162.74 $86.4 Million - $90.6 Million	556,518 New	556,518 $88 Billion
Q4 2023 Aug 14, 2024	BUY	$145.6 - $158.88 $1.37 Million - $1.49 Million	9,387 Added 2.2%	435,805 $68.3 Billion
Q3 2023 Aug 14, 2024	SELL	$155.75 - $174.48 $6.27 Million - $7.02 Million	-40,230 Reduced 8.62%	426,418 $66.4 Billion
Q2 2023 Aug 14, 2024	BUY	$154.35 - $166.11 $12 Million - $12.9 Million	77,621 Added 19.95%	466,648 $77.2 Billion
Q1 2023 Aug 14, 2024	BUY	$151.05 - $180.26 $983,788 - $1.17 Million	6,513 Added 1.7%	389,027 $60.3 Billion
Q4 2022 Aug 14, 2024	BUY	$160.2 - $179.79 $2.13 Million - $2.39 Million	13,317 Added 3.61%	382,514 $67.6 Billion
Q3 2022 Aug 14, 2024	BUY	$161.33 - $179.52 $924,743 - $1.03 Million	5,732 Added 1.58%	369,197 $60.3 Billion
Q2 2022 Aug 14, 2024	SELL	$168.19 - $186.01 $2.32 Million - $2.57 Million	-13,817 Reduced 3.66%	363,465 $64.5 Billion
Q1 2022 Aug 14, 2024	SELL	$158.14 - $179.59 $31 Million - $35.1 Million	-195,722 Reduced 34.16%	377,282 $66.9 Billion
Q4 2021 Aug 30, 2024	SELL	$155.93 - $173.01 $1.85 Million - $2.05 Million	-11,857 Reduced 3.0%	383,682 $65.6 Billion
Q3 2021 Aug 30, 2024	BUY	$161.5 - $179.47 $5.75 Million - $6.39 Million	35,584 Added 9.89%	395,539 $63.9 Billion
Q2 2021 Aug 30, 2024	SELL	$159.48 - $171.07 $34 Million - $36.4 Million	-213,049 Reduced 37.18%	359,955 $59.3 Billion
Q1 2021 Aug 30, 2024	BUY	$153.07 - $170.48 $565,899 - $630,264	3,697 Added 1.06%	352,998 $58 Billion
Q4 2020 Aug 30, 2024	BUY	$137.11 - $157.38 $6.63 Million - $7.61 Million	48,331 Added 16.06%	349,301 $55 Billion
Q3 2020 Aug 30, 2024	SELL	$140.38 - $153.83 $1.31 Million - $1.43 Million	-9,302 Reduced 3.0%	300,970 $44.8 Billion
Q2 2020 Aug 30, 2024	BUY	$128.81 - $155.51 $662,856 - $800,254	5,146 Added 1.69%	310,272 $43.6 Billion
Q1 2020 Aug 30, 2024	SELL	$111.14 - $153.99 $2.03 Million - $2.81 Million	-18,243 Reduced 5.64%	305,126 $40 Billion
Q4 2019 Aug 30, 2024	SELL	$127.5 - $146.44 $871,080 - $1 Million	-6,832 Reduced 2.07%	323,369 $47.2 Billion
Q3 2019 Aug 30, 2024	SELL	$126.95 - $142.14 $1.51 Million - $1.7 Million	-11,931 Reduced 3.49%	330,201 $42.7 Billion
Q2 2019 Aug 30, 2024	SELL	$131.15 - $144.24 $10.6 Million - $11.6 Million	-80,510 Reduced 19.05%	342,132 $47.7 Billion
Q1 2019 Aug 30, 2024	SELL	$125.72 - $139.79 $3 Million - $3.34 Million	-23,901 Reduced 5.35%	422,642 $59.1 Billion
Q4 2018 Aug 30, 2024	SELL	$122.84 - $147.84 $15.5 Million - $18.7 Million	-126,461 Reduced 22.07%	446,543 $57.6 Billion
Q3 2018 Aug 30, 2024	BUY	$121.58 - $142.88 $495,681 - $582,521	4,077 Added 0.89%	462,018 $63.8 Billion
Q2 2018 Aug 30, 2024	BUY	$119.4 - $131.76 $5.75 Million - $6.34 Million	48,120 Added 11.74%	457,941 $55.6 Billion
Q1 2018 Aug 30, 2024	BUY	$125.1 - $148.14 $2.13 Million - $2.53 Million	17,064 Added 4.34%	409,821 $52.5 Billion
Q4 2017 Aug 30, 2024	BUY	$131.22 - $143.62 $204,834 - $224,190	1,561 Added 0.4%	392,757 $54.9 Billion
Q3 2017 Aug 30, 2024	BUY	$129.47 - $135.38 $314,223 - $328,567	2,427 Added 0.62%	391,196 $50.9 Billion
Q2 2017 Aug 30, 2024	SELL	N/A	-184,235	388,769 $51.4 Billion

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account

Federation Des Caisses Desjardins Du Quebec Johnson & Johnson Transaction History